Comparison of the Efficacy of Metformin and Inofolic in Ovulatio

Phase 2

• Conditions: polycystic ovarian syndrome(PCOS).; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20200816048427N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Presence of Oligomenorrhoea
Presence of Amenorrhea
Presence of Polycysticovarian Evidence in Ultrasound
Hypergonadism
Lack of Response to Ovulation Induction Therapy

Exclusion Criteria

Lack of patient cooperation
Inability to follow treatment for 3 months.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Follicular growth. Timepoint: The size of the follicles at the beginning of treatment (before the intervention) and 90 days after the start of metformin and inofolic. Method of measurement: transvaginal ultrasonography.

Secondary Outcome Measures

Name	Time	Method
umber of dominant follicles. Timepoint: At the beginning of the study (before the intervention) and 90 days after the start of metformin and inofolic. Method of measurement: transvaginal ultrasonography.